• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,909.65
    642.25 (+1.18%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,403.50(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Ather Energy
    1,782.05 1,741.90(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Laurus Labs
    2,392.00 2,245.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 816.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 36.30(%)
  • Godrej Consumer
    777.65 810.35(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 51.30(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Laurus Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 45955.0
  • ISIN : INE947Q01028
2,244.00 62 (2.85%)
  • As on 30 Oct 2026 (EOD)

  • Today’s Low

    2,166.00

  • Today’s High

    2,244.00

  • Open

    2,190.00

  • Perv Close

    2,181.90

  • 52W Low

    917.95

  • 52W High

    2,244.00

Key Indicators

  • P/E(TTM)

    139.01

  • Mar.Cap (₹Cr.)

    121,246.06

  • Div & Yield %

    0.09

  • Book Value(₹)

    97.20

  • Debt-Equity Ratio

    2.85

  • AGM Date

    29-Oct-2026

  • EPS

    16.15

  • P/E Ratio

    139.01

Financials Ratios

  • Debt-Equity Ratio

    0.56

  • Mar.Cap (₹Cr.)

    121,246.06

  • RONW (%)

    4.13

  • ROCE (%)

    6.31

Score Board

  • Equity (₹ in Cr.)

    108.06

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    6,089.07

  • NP (in Cr.)

    743.65

  • NP Var(%)

    144.0

  • Div%

    100.0

  • CPS (₹)

    20.80

  • EPS (₹)

    13.80

  • Traded Value (₹ in Lakhs)

    121,300.09

  • 52 Week High

    2,244.00

  • 52 Week Low

    917.95

  • Price BSE

    2245.0

  • Price NSE

    2,244.00

  • Market Capital( in Cr.)

    121,300.09

  • P/C Ratio

    108.10

  • P/E Ratio

    163.10

  • Price Vs.BV

    13.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6,089.07 5,216.98 4,812.39 5,773.45 4,707.04 4,768.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,089.07 5,216.98 4,812.39 5,773.45 4,707.04 4,768.72
Other Income 77.43 100.47 47.42 15.95 21.55 27.32
Stock Adjustments 236.87 13.55 102.48 -40.82 218.62 296.45
Total Income 6,403.37 5,331.00 4,962.29 5,748.58 4,947.21 5,092.49
EXPENDITURE :            
Raw Materials 2,797.49 2,476.74 2,507.87 2,671.65 2,427.18 2,471.58
Power and Fuel Cost 330.61 289.49 309.67 301.10 188.52 149.69
Employee Cost 683.52 570.78 531.93 477.88 417.57 364.83
Other Manufacturing Expenses 585.95 482.35 491.94 431.99 326.34 298.12
Selling and Administration Expenses 393.76 393.12 293.96 323.95 265.52 260.60
Miscellaneous Expenses 96.35 73.72 29.62 44.30 15.33 10.48
Employee Benefit Expenses 683.52 570.78 531.93 477.88 417.57 364.83
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,887.68 4,286.20 4,164.99 4,250.87 3,640.46 3,555.30
Operating Profit 1,515.69 1,044.80 797.30 1,497.71 1,306.75 1,537.19
Interest 142.96 182.20 150.82 145.70 95.86 65.92
Gross Profit 1,372.73 862.60 646.48 1,352.01 1,210.89 1,471.27
Depreciation 378.64 358.79 345.01 300.58 235.48 196.64
Profit Before Tax 994.09 503.81 301.47 1,051.43 975.41 1,274.63
Current Tax 285.12 153.84 87.94 270.78 231.42 334.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -31.51 -30.42 -10.17 20.27 -6.10 -16.46
Reported Net Profit 740.48 380.39 223.70 760.38 750.09 956.11
Extraordinary Items -3.17 75.87 -0.57 -0.14 -0.85 -0.63
Adjusted Net Profit 743.65 304.52 224.27 760.52 750.94 956.74
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3,704.87 3,367.61 3,230.09 2,577.18 1,912.95 1,031.88
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 86.33 43.13 86.18 107.47 85.86 75.04
P & L Balance carried down 4,359.02 3,704.87 3,367.61 3,230.09 2,577.18 1,912.95
Dividend 86.33 43.13 86.18 107.47 85.86 75.04
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 60.00 40.00 100.00 100.00 100.00
Dividend Per Share(Rs) 2.00 1.20 0.80 2.00 2.00 2.00
Earnings Per Share-Unit Curr 13.72 7.05 4.15 14.12 13.96 17.82
Earnings Per Share(Adj)-Unit Curr 13.72 7.05 4.15 14.12 13.96 17.82
Book Value 97.29 84.64 78.06 75.31 63.05 50.54
Book Value(Adj)-Unit Curr 97.29 84.64 78.06 75.31 63.05 50.54

Shareholding Pattern

  • Promoter Group

    27.47%

  • Public Share Holding

    72.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,089,357 3.35 18,089,357 16
Partnership Firms-Indian (Promoter & Group) 130,331,740 24.12 130,331,740 2
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 148,421,097 27.47 148,421,097 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 99,811 0.02 99,811 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 166,628,382 30.84 166,628,382 709
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 12,693,241 2.35 12,693,241 19
Mutual Funds / UTI 44,636,072 8.26 44,636,072 38
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,638,765 1.23 6,638,765 45
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 230,696,271 42.70 230,696,271 813
2] Non Institution
Bodies Corporate 36,718,955 6.80 36,718,955 1,739
Clearing Members 3,355,751 0.62 3,355,751 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,640,591 1.23 6,640,591 7,462
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,605,961 0.48 2,605,961 4,328
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 42,557,094 7.88 42,557,094 98
Individuals holding nominal share capital up to Rs. 1 lakh 65,643,831 12.15 65,643,831 297,410
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 237,417 0.04 237,417 12
Others 3,435,250 0.64 3,435,250 3
Sub Total 161,194,850 29.83 161,194,850 311,061
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 540,312,218 100.00 540,312,218 311,892

Company Background

Laurus Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Laurus Labs Ltd
  • BSE Code : 45955.0
  • ISIN : INE947Q01028

  • Incorporation Year

    2005

  • Registered Office

    Plot No 21 Jawaharlal Nehru
    Pharma City Parawada, Visakhapatnam,
    Andhra Pradesh-531021

  • Telephone

    91-891-3061222

  • FAX

    91-891-3061270

  • Chairman

    Ravindranath Kancherla

  • Managing Director

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Laurus Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Laurus Labs 2,245.00 6,166.50 6,089.07 139.01 14.95
Abbott India 26,107.90 7,217.19 6,929.05 34.36 43.78
Astrazeneca Phar 6,298.05 2,304.07 2,275.58 92.82 27.86
Glaxosmi. Pharma 2,515.65 3,932.76 3,790.20 40.19 58.17
Novartis India 1,813.30 393.10 354.33 45.79 15.94
Cipla 1,357.00 20,102.60 18,979.95 41.36 13.88
Bliss GVS Pharma 682.50 773.53 729.81 63.43 12.51
Amrutanjan Healt 493.40 520.13 502.55 26.43 24.16
Fermenta Biotec. 439.75 474.15 450.25 20.53 18.77
Guj. Themis Bio. 374.85 168.25 165.82 100.23 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77